Skip to main content
. 2018 May 25;9(40):26064–26071. doi: 10.18632/oncotarget.25436

Figure 2. Top 10 drugs.

Figure 2

with (A) HPV-positive and (B) HPV-negative selective potency from Kinase inhibitor and Tocris compound panels.